ASCO 2023: Update on PROSPECT Trial Results from Dr. Alan Venook

Highlights at ASCO 2023Подробнее

Dr. Alan P. Venook on Determining Frontline Treatment for mCRCПодробнее

Dr. Venook Discusses the Results of the 80405 TrialПодробнее

Venook: What are the principal options to control metastatic disease ?Подробнее

CALGB 80405 Trial Results in Metastatic Colorectal CancerПодробнее

PROSPECT: neoadjuvant CRT vs FOLFOX in locally advanced rectal cancerПодробнее

Key clinical trial updates from ASCO GI 2023Подробнее

What to look forward to in urothelial cancer at ASCO GU 2023Подробнее

Colorectal Cancer Treatment from ASCO 2014Подробнее

ASCO 2023 Expert Report on novelties in the treatment of colorectal cancer by S. StintzingПодробнее

Genitourinary cancer updates at ASCO 2023Подробнее

Alan Venook, MD, discusses next generation sequencing and mCRC treatmentПодробнее

Trials to watch in rectal cancerПодробнее

Alan Venook, MD, provides opinions of the OPRA data in rectal cancer patients presented at ASCO20Подробнее

Dr. Alan Venook on Using Frailty Index & Geriatric AssessmentsПодробнее

Dr. Venook Discusses Implications of the CALGB/SWOG 80405 StudyПодробнее

Who will benefit the most from adjuvant IO in melanoma?Подробнее